A comprehensive view of Novartis AG. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Transformation & Innovation Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

US Patent Issued to Novartis on April 16 for "Solid forms comprising an oxime ether compound, compositions and methods of use thereof" (New Jersey Inventors)
Published: April 17, 2024 by U.S. Fed News
US Patent Issued to Novartis on April 16 for "Urea compounds and compositions as SMARCA2/BRM ATPase inhibitors" (American, Canadian Inventors)
Published: April 17, 2024 by U.S. Fed News
Patent Issued for ENTPD2 antibodies, combination therapies, and methods of using the antibodies and combination therapies (USPTO 11939397)
Published: April 17, 2024 by Immunotherapy Daily
Patent Issued for BCMA chimeric antigen receptors and uses thereof (USPTO 11939389)
Published: April 17, 2024 by NewsRx Pharma Business Daily
Delhi HC Affirms Ad Interim Injunction in Favour of Novartis for Patent Infringement by Natco Pharma
Published: April 16, 2024 by MoneyLife

Ask us about our Transformation & Innovation market view

Trending Chart

Interactive chart with headline count